Goorma ayuu Glenmark Pharmaceuticals Limited ku soo daabacayaa warbixinta faa'idada iyo khasaaraha?Warbixinta faa'iidada iyo khasaaraha ee Glenmark Pharmaceuticals Limited ayaa la daabacaa hal mar rubuc, warbixinta ugu dambeysay ee maaliyadeed ee Glenmark Pharmaceuticals Limited ayaa la daabacay 31/03/2018. Maxay faa'iido ka tahay saamiyada Glenmark Pharmaceuticals Limited?Dakhliga la qiyaasay ee qaybta ka ah Glenmark Pharmaceuticals Limited waxay ahaayeen 5.37 Rs warbixintii ugu dambeysay ee dhaqaalaha. Goorma ayuu Glenmark Pharmaceuticals Limited ku daabici doonaa warbixinta faa'idada iyo khasaaraha soo socda?Warbixinta soo socota ee xisaabta faa'iidada iyo khasaaraha Glenmark Pharmaceuticals Limited waxay noqon doontaa June 2024. Glenmark Pharmaceuticals Limited Dakhliga saami qaybsiga urur dhaqaale waa tusaha xisaabeed ee guusha shirkad, kuxiran qiimaha ururka laftiisa. Dakhliga saami kasta ayaa loo xisaabiyaa si fudud - dhammaan faa'iidooyinka shirkadda ee muddadda maaliyadeed ee warbixinta waxay u qaybsantaa tirada saamiyada. Glenmark Pharmaceuticals Limited Dakhliga saami kasta waxaa loo xisaabiyaa mid kasta oo dhaqaale oo kasta. Faa'iidada Glenmark Pharmaceuticals Limited - wadarta guud ee macaashka xilliga warbixinta. |
|||||||||||||||||
|
|||||||||||||||||
Faa'iido Glenmark Pharmaceuticals LimitedGlenmark Pharmaceuticals Limited macaashka guud waa tixraac kaliya mana ahan mid xiiso u leh saamilayda shaqsiyaadka. Waxa ka sii muhiimsan waa xisaabinta dakhliga soo gala saamiga. Qiimahaani waa aasaaska xisaabinta saami qeybsiga waxaana aad ugu badan baahida ay u qabaan dareenka saamileyda. Taarikhda warbixinta faa iidada Glenmark Pharmaceuticals Limited waxaa lagu xirey sharciga wadanka ee diwaangalinta shirkada. Taariikh kasta oo Glenmark Pharmaceuticals Limited Bayaanka faa'idada wuxuu u dhigmaa xariiq miiska adeegga. |
|||||||||||||||||
|
|||||||||||||||||
Quarterly faa'iido Glenmark Pharmaceuticals LimitedDakhliga saamiga Glenmark Pharmaceuticals Limited "waxaa loo xisaabiyaa iyadoo loo eegayo qaaciddada: dakhliga saafiga ah ee loo qaybiyey wadarta tirada saamiyada shirkadda. Dakhliga saamiga Glenmark Pharmaceuticals Limited waxaa lagu go'aamiyaa waqti cayiman oo dhaqaale waxayna u dhigantaa natiijooyinka bayaanada maaliyadeed ee macaashka shirkadda. Glenmark Pharmaceuticals Limited Dakhliga saami qaybsiga muddadii ugu dambeysay waxay ku qoran yihiin garaafka safka ugu dambeeya. Saddex-laablaha Glenmark Pharmaceuticals Limited waa nooca ugu weyn ee xisaabaadka maaliyadeed ee shirkadaha. |
|||||||||||||||||
Glenmark Pharmaceuticals Limited Dakhliga sedex biloodlaha ah saamiga waa qiyaasta faa'iidada shirkada. Waxay leeyihiin muhiimad dhexdhexaad ah oo ka dhexeysa falanqeeyayaasha. Laakiin dakhliga sanadlaha ah ee saami kasta waa muhiimadda koowaad. Faa'iidada rubuc-qarnigii la soo dhaafay Glenmark Pharmaceuticals Limited ee maanta waxay ka dhigan tahay faa iidada la daabacay rubuc qarnigii la soo dhaafay. Isbeddelka faa iidada Glenmark Pharmaceuticals Limited ee sanadka waa qiime loo xisaabay macluumaadka dheeriga ah ee muujinaya isbeddelka boqolkiiba macaashka isla muddadi sanadkii la soo dhaafay. Isbeddelka Glenmark Pharmaceuticals Limited faa'iidada rubuc-sannadeedka sanadka muhiim ma ahan maadaama isbadal lagu sameeyo Glenmark Pharmaceuticals Limited "macaashka sanadkii marka la barbar dhigo sanadkii la soo dhaafay. Isbeddelka faa iidada ayaa loo muujiyay boqolley ahaan. Jadwalka adeegga Quarterly Profit-ka ee boggan, waxaad ka heli kartaa taariikhda Glenmark Pharmaceuticals Limited macaashka xilliyadii hore ee warbixinta, sanadkii la soo dhaafay ama kala-sooc kale. Glenmark Pharmaceuticals Limited Taariikhda dakhliga saddex-biloodlaha ah waxaa laga heli karaa internetka 10-kii sano ee la soo dhaafay. The Glenmark Pharmaceuticals Limited keydka macaashka shirkadda sanadihii hore waxaa laga soo qaatay ilo furan. |
Kharashka saamiyada Glenmark Pharmaceuticals Limited |
||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Maaliyadda Glenmark Pharmaceuticals Limited |
||||||||||||||||||||||||||||||||||||||
|
|
|